Header Logo

Connection

HOWARD WEINER to Biomarkers

Back to Details
This is a "connection" page, showing publications HOWARD WEINER has written about Biomarkers.
HOWARD WEINER
Connection Strength
0.600
Biomarkers
  1. Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Nov; 12(6):e200466.
    View in: PubMed
    Score: 0.117
  2. Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Nat Commun. 2024 May 20; 15(1):4297.
    View in: PubMed
    Score: 0.107
  3. Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study. Front Immunol. 2021; 12:709861.
    View in: PubMed
    Score: 0.088
  4. Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis. J Neurol Neurosurg Psychiatry. 2025 Oct 15; 96(11):1046-1052.
    View in: PubMed
    Score: 0.029
  5. Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity. Neurol Neuroimmunol Neuroinflamm. 2023 11; 10(6).
    View in: PubMed
    Score: 0.026
  6. Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023 01; 10(1).
    View in: PubMed
    Score: 0.024
  7. Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS): a prospective observational protocol to identify biomarkers of seizure response in children and youth. BMJ Open. 2022 04 08; 12(4):e055886.
    View in: PubMed
    Score: 0.023
  8. Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures. Front Immunol. 2021; 12:664344.
    View in: PubMed
    Score: 0.022
  9. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis. Ann Clin Transl Neurol. 2021 03; 8(3):631-638.
    View in: PubMed
    Score: 0.021
  10. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis. J Neuroimaging. 2021 03; 31(2):388-393.
    View in: PubMed
    Score: 0.021
  11. Perioperative Procalcitonin in Predicting Infection in Children Undergoing Surgical Procedures. J Surg Res. 2021 02; 258:332-338.
    View in: PubMed
    Score: 0.021
  12. Serum antibodies to phosphatidylcholine in MS. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4).
    View in: PubMed
    Score: 0.020
  13. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Ann Clin Transl Neurol. 2020 06; 7(6):945-955.
    View in: PubMed
    Score: 0.020
  14. Protein Degradome of Spinal Cord Injury: Biomarkers and Potential Therapeutic Targets. Mol Neurobiol. 2020 Jun; 57(6):2702-2726.
    View in: PubMed
    Score: 0.020
  15. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018 Aug; 58(2):261-269.
    View in: PubMed
    Score: 0.017
  16. An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy. Mult Scler. 2014 Sep; 20(10):1381-90.
    View in: PubMed
    Score: 0.013
  17. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 2009 Jun 02; 72(22):1922-30.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.